[Snitrosylating protein disulphide isomerase mediates increased expression of α synuclein caused by methamphetamine in mouse brain].

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University

• Publication date

  2017-10-20

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 29070471PMCID PMC6743953
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro α-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains.

  2017cited by this paper
• [Effect of methamphetamine exposure on S-nitrosylation of protein disulphide isomerase in PC12 cells].

  2017cited by this paper
• Role of PUMA in methamphetamine-induced neuronal apoptosis.

  2016cited by this paper
• Effects of DDIT4 in Methamphetamine-Induced Autophagy and Apoptosis in Dopaminergic Neurons

  2016cited by this paper
• Protein S-Nitrosylation as a Therapeutic Target for Neurodegenerative Diseases.

  2016cited by this paper
• Cholecystokinin-8 inhibits methamphetamine-induced neurotoxicity via an anti-oxidative stress pathway.

  2016cited by this paper
• Recent Advances in Methamphetamine Neurotoxicity Mechanisms and Its Molecular Pathophysiology

  2015cited by this paper
• The Thioredoxin Superfamily in Oxidative Protein Folding

  2014cited by this paper
• S-Nitrosylating protein disulphide isomerase mediates α-synuclein aggregation caused by methamphetamine exposure in PC12 cells.

  2014cited by this paper
• Expression and Activity of Nitric Oxide Synthase Isoforms in Methamphetamine-Induced Striatal Dopamine Toxicity

  2013cited by this paper
• Up-regulation of protein tyrosine nitration in methamphetamine-induced neurotoxicity through DDAH/ADMA/NOS pathway.

  2013cited by this paper
• RNA interference targeting α-synuclein attenuates methamphetamine-induced neurotoxicity in SH-SY5Y cells.

  2013cited by this paper
• α‐Synuclein oligomers and clinical implications for Parkinson disease

  2013cited by this paper
• Toxicity of amphetamines: an update

  2012cited by this paper
• Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs.

  2012cited by this paper
• Involvement of S-Nitrosylation in Neurodegeneration

  2011cited by this paper
• Involvement of DDAH/NOS pathway in methamphetamine-induced neurotoxicity in rat striatum

  2010cited by this paper
• Methamphetamine toxicity and messengers of death.

  2009cited by this paper
• Proteomic profiling of proteins associated with methamphetamine-induced neurotoxicity in different regions of rat brain.

  2008cited by this paper
• Chronic stress enhances methamphetamine‐induced extracellular glutamate and excitotoxicity in the rat striatum

  2008cited by this paper
• Protective effects of interferon-gamma against methamphetamine-induced neurotoxicity.

  2008cited by this paper
• Selective inhibition of cyclooxygenase-2 exacerbates methamphetamine-induced dopamine depletion in the striatum in rats.

  2007cited by this paper
• Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells.

  2002cited by this paper
• Roles of Glutamate, Nitric Oxide, Oxidative Stress, and Apoptosis in the Neurotoxicity of Methamphetamine

  2002cited by this paper
• Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

  2001cited by this paper
• Aging increases the susceptiblity to methamphetamine‐induced dopaminergic neurotoxicity in rats: correlation with peroxynitrite production and hyperthermia

  2001cited by this paper

• Methamphetamine induced neurotoxic diseases, molecular mechanism, and current treatment strategies.

  2022cites this paper
• Effect of Parkin on methamphetamine‐induced α‐synuclein degradation dysfunction in vitro and in vivo

  2020cites this paper